A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.
@article{Hunter1994ACO, title={A case of hepatoma associated with hypoglycaemia and overproduction of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin.}, author={Steven J Hunter and William H. Daughaday and Michael E. Callender and J Mcknight and E. M Mcilrath and J. D. Teale and A. Brew Atkinson}, journal={Clinical endocrinology}, year={1994}, volume={41 3}, pages={ 397-401; discussion 402 } }
- Published 1994 in Clinical endocrinology
We describe a case of recurrent hypoglycaemia associated with a hepatoma. During hypoglycaemia serum insulin was undetectable. Plasma insulin-like growth factor II (IGF-II) was not elevated although 71% of plasma IGF-II was present as big IGF-II (molecular weight 11 kDa) which probably represents a non-glycated form of pro-IGF-II. The GH response to hypoglycaemia was impaired and plasma levels of both IGF-I and the GH-dependent IGF binding protein (IGFBP-3) were low. A recently described… CONTINUE READING